The Integra-D trial shows the device, which provides cardiac contractility modulation and defibrillation, also eases symptoms ...
On top of performing implantable cardioverter-defibrillator (ICD) functions, the integrated device also delivered appropriate ...
There is a lower risk of 1-year ventricular arrhythmias or death in women with nonischemic cardiomyopathy and an implantable cardioverter defibrillator (ICD) compared with men.
Aim In the UK, pharmacological management of patients with heart failure (HF) occurs predominantly in general practice. Using ...
All electrophysiologists had performed at least 20 successful implantations prior to the study. The primary endpoint was a ...
Heart issues can strike at any time, with no warning. And they can often require serious surgeries or interventions to fix ...
The global implantable defibrillator market is projected to grow at a CAGR of ~7% during the forecast period. The growth is ...